Zapain (Acetaminophen,Codeine)

Quick links to important sections

Zapain (Acetaminophen,Codeine)

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Zapain (Acetaminophen,Codeine)

Quick Facts

Property Description
Active ingredients Acetaminophen (Non-opioid) and Codeine (Opioid agonist)
Form Oral preparation (Tablet or Capsule)
Pharmacological class Compound analgesic (Combination analgesic)
Common use Relief of moderate pain
Origin Synthetic/Derived Combination

What Type of Medicine is Zapain: Classification and Identity

Zapain is medically defined as a fixed-dose combination analgesic, fundamentally classified as a compound analgesic used for the management of pain. This pairing is utilized to relieve mild to moderate pain. This formulation is designed to provide a greater therapeutic benefit than either ingredient used as a stand-alone medication. Zapain, as a brand, is often a prescription-only medicine (POM) and is essentially a high-strength formulation containing the same active ingredients as Co-codamol.

Composition and Form: The Combination of Acetaminophen and Codeine

Zapain is composed of two distinct active ingredients: Acetaminophen (known as Paracetamol), which functions as a non-opioid analgesic, and Codeine, which is classified as a centrally acting opioid agonist. The formulation is a blend of a synthetic substance (Acetaminophen) and a derived substance (Codeine, a natural alkaloid derivative). This combination is used for the treatment of pain through a synergistic action of the two molecules. The drug is presented as a solid pharmaceutical vehicle, typically a tablet or capsule, designed for oral administration.

The Dual-Pathway Approach to Analgesia

The general therapeutic intent of Zapain leverages a dual-pathway approach to achieve its analgesic effect. Codeine acts centrally within the central nervous system (CNS), modifying the perception of pain, while Acetaminophen modulates pain signals and provides an antipyretic effect. This integrated mechanism is intended for patients experiencing moderate pain when non-opioid options are insufficient, providing comprehensive pain intervention.

Regulatory References

  1. MedlinePlus

What side effects are possible with Zapain (Acetaminophen,Codeine)?

Possible Side Effects and Safety Information

The officially documented safety profile for the Acetaminophen/Codeine combination is structured by the frequency and organ systems affected, as defined by government regulatory authorities.

Adverse Reaction Classification

The most Common adverse reactions listed in regulatory documents are associated with the Codeine component's effects on the central nervous system and include Drowsiness, Lightheadedness, Sedation, Nausea, Vomiting, and Constipation. These effects are grouped under Gastrointestinal Disorders and Nervous System Disorders in official System-Organ Classifications (SOCs).

Other less frequent events include Pruritus (itching) and Skin rash.


Serious Adverse Reactions and Key Constraints

Regulatory labeling highlights specific Serious Adverse Reactions. The most critical risks documented are Life-threatening Respiratory Depression (related to Codeine), the potential for Severe Hepatotoxicity or liver injury (related to Acetaminophen, particularly in overdose), and the risk of Opioid Addiction, Abuse, and Misuse. The risk of respiratory depression is often highest during the initiation of therapy or following a dose increase.

Repeated use can lead to Physical Dependence, with Withdrawal Symptoms occurring upon abrupt cessation. The label mandates specific Population-Specific Safety Constraints:

  • Pediatric Contraindication: The medicine is Contraindicated in children younger than 12 years.
  • Lactation Restriction: It is Contraindicated in breast-feeding women due to the risk of serious adverse reactions in the infant.

Official safety profiles also note the need for caution in older adults and patients with severe impairment of renal or hepatic function.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Zapain is defined by a dual-toxicity risk stemming from its two active ingredients: potentially life-threatening opioid toxicity (Codeine) and severe hepatotoxicity (Acetaminophen). Documented manifestations from the Codeine component include respiratory depression (shallow, slow breathing), extreme somnolence progressing to coma, pinpoint pupils, and low blood pressure. The Acetaminophen component presents a critical risk of acute hepatic failure, with initial symptoms (nausea, vomiting, sweating) often being mild or delayed by 24 to 48 hours.

Immediate medical attention is required upon any suspected overdose, even without initial symptoms, due to the documented danger of delayed, severe liver injury. Regulatory management requires the use of the specific antidotes Naloxone (for opioid effects) and N-acetyl cysteine (NAC) (for Acetaminophen poisoning). Overdose is officially documented to carry the risk of fatal outcome in children from accidental ingestion of even a single dose, highlighting a key population-specific consideration. Continuous surveillance and monitoring of vital signs and serial hepatic enzymes are mandated parts of the official management protocol.

Therapeutic Uses of Zapain (Acetaminophen,Codeine)

What Zapain (Acetaminophen/Codeine) Treats: Main Uses and Benefits

This combination medication is considered relevant for easing symptoms related to physical discomfort of mild to moderate intensity. It is generally applied in contexts where additional symptomatic support is needed, primarily across conditions presenting with acute episodes such as postoperative pain, discomfort following a physical injury (post-traumatic), and pronounced osteoarticular or dental pain. This makes it applicable in clinical settings that involve acute or unstable symptom patterns.

This supportive relief may assist with contributing to improved comfort during periods of heightened symptoms. The formulation provides the benefit of addressing symptoms related to systemic imbalance, specifically fever, alongside physical discomfort. This combination may be part of symptomatic management to help ease the overall symptom load.

“This medicine is relevant when supportive symptom management is appropriate, particularly for discomfort that interferes with routine activities.”


Quick Fact: Used for Managing Discomfort

Parameter Description
Primary Use Focus Used for managing symptoms related to physical discomfort
Key Symptom Axes Physical discomfort, systemic imbalance
Scenario Example Postoperative and post-traumatic acute pain
Patient Benefit May assist with maintaining functional stability

Regulatory References

  1. NIH MedlinePlus overview of Acetaminophen and Codeine

Eligibility and Restrictions for Use

The eligibility for Zapain (Acetaminophen/Codeine) is strictly defined by regulatory authorities based on age, metabolic profile, and pre-existing health conditions.

The medicine is generally reserved for adults and adolescents 12 years of age and older.

Use is absolutely contraindicated in several populations. These include children under 12 years of age, and all pediatric patients following surgery for obstructive sleep apnea. Women who are breastfeeding must not use this medicine. It is also contraindicated for patients with known hypersensitivity to its active components or those diagnosed as CYP2D6 ultra-rapid metabolizers. Absolute restrictions also apply to individuals with severe hepatic failure, moderate to severe renal impairment, or significant acute respiratory depression.

Certain groups require conditional use or are not recommended. Use is strongly advised against in adolescents (12–18 years) with respiratory risk factors like obesity. Furthermore, caution is required for the elderly, frail patients, and those with less severe organ impairment. Prolonged use during pregnancy is highly restricted due to the documented risk of Neonatal Opioid Withdrawal Syndrome.

What should I know about interactions with other medicines?

Zapain is a combination product whose interaction profile is defined by both the acetaminophen and codeine components. Codeine, an opioid, presents the most critical interaction risks, primarily due to additive CNS depression. Concomitant use with alcohol, benzodiazepines, or other Central Nervous System (CNS) depressants can lead to profound sedation, respiratory depression, coma, and death. If combination is required, the dosage and duration should be strictly limited.

Simultaneous use with Monoamine Oxidase Inhibitors (MAOIs), including Isocarboxazid, Phenelzine, or Tranylcypromine, is contraindicated; a 14-day washout period is mandatory when switching between these drug classes. Use with other serotonergic drugs may precipitate Serotonin Syndrome.

The codeine component is metabolized by CYP2D6 and CYP3A4 enzymes, meaning that co-administration with inhibitors or inducers of these enzymes can alter the formation of the active metabolite, morphine, potentially affecting efficacy or increasing the risk of adverse effects. Acetaminophen interactions mainly involve anticoagulants (e.g., Warfarin), where co-administration requires monitoring due to a potential increase in bleeding risk. Patients must not combine this product with any other medicine containing acetaminophen to avoid exceeding the maximum daily dose and risking severe liver damage.

Mechanism of Action

The mechanism of action of Zapain involves the distinct but synergistic pharmacological effects of its two components: acetaminophen and codeine. The combination produces modulation of central and peripheral nociceptive pathways.

Acetaminophen Mechanism Acetaminophen works by inhibiting cyclooxygenase (COX) enzymes primarily in the central nervous system (CNS), which reduces the synthesis of prostaglandins. This reduced synthesis is hypothesized to be linked to the modulation of both the thermal regulatory center in the hypothalamus and descending inhibitory pathways, altering central signal transduction.

Codeine Mechanism Codeine is an opioid agonist that acts primarily on the mu-opioid receptor (MOR) within the CNS. Following administration, codeine undergoes O-demethylation by the hepatic cytochrome P450 enzyme CYP2D6 to form the active metabolite morphine. Morphine binds to the MOR, triggering G-protein coupled inhibition of adenylyl cyclase and a subsequent reduction in intracellular cAMP levels. This binding also promotes potassium ion efflux and reduction of calcium ion influx at the pre- and post-synaptic terminals of neurons, resulting in cellular hyperpolarization.

Dosage and Administration Information

Zapain is an oral preparation administered as a tablet, capsule, or liquid solution, utilized according to specific frequency and dosage limitations established for this formulation. The medication is generally taken on an as-needed basis, with dosing restricted to an interval of every four to six hours. The minimum required time between doses, particularly for the higher-strength formulations, is not less than six hours.

For adult use, the typical dose is one or two units per administration. The total amount of acetaminophen (paracetamol) consumed is carefully monitored, as guidelines mandate a total daily limit that does not exceed 4000 mg from all sources. There is a restriction against the co-administration of this medicine with any other products containing acetaminophen or paracetamol.

Administration can occur with or without food. If the formulation is a soluble tablet, it must be fully dissolved in water before intake, while liquid forms require precise measurement using a marked device. A characteristic constraint for the management of acute pain is that use is typically limited to a maximum of three consecutive days. Furthermore, the combination is not recommended for administration to children under the age of 12. Dose adjustments, including extended intervals (e.g., eight hours), are utilized for older adults and individuals with hepatic or severe renal impairment, forming a structured protocol for usage.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Long-Term Outcomes in Chronic Heart Failure

Studies investigated whether the long-term prognosis of patients with chronic heart failure (CHF) is affected by the medication. Research has explored the relationship between the drug and the strain on the heart muscle.


Key Clinical Trial Findings

Clinical studies examined the frequency of major cardiac events, such as heart attack and stroke, in patients receiving the medication. Research evaluated changes in blood pressure over time.


Safety and Tolerability Profile

Studies monitored reported side effects, and research continues to evaluate long-term use. Studies evaluated drug interactions with potassium supplements. The combined use was a noted area of review.


Conclusion of Research

Usage details were specific to each study and patient group, and varied. Overall, the evidence was descriptive of the outcomes in the study participants.

Key Studies & References

  1. ACETAMINOPHEN AND CODEINE tablet – DailyMed (FDA Label)
  2. Codeine: MedlinePlus Drug Information (NIH/NLM)
  3. Codeine - StatPearls (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Zapain (Acetaminophen,Codeine) (FAQ)


Q: How is Zapain different from regular paracetamol (acetaminophen) tablets?

Official product information classifies Zapain as a compound analgesic, meaning it contains two different active ingredients. This structure is intended to produce a synergistic effect, which regulatory documents describe as being recognized to offer an enhanced therapeutic benefit compared to using either the acetaminophen or the codeine component alone.


Q: How long does it usually take for Zapain to start relieving pain?

According to official regulatory data, the analgesic effect of Zapain begins relatively quickly after administration. The onset of pain relief is generally documented to occur within 30 to 60 minutes.


Q: What is the typical duration of pain relief expected from one dose of Zapain?

Studies cited in regulatory sources indicate the typical therapeutic window for this medication. The duration of pain relief expected from a single dose is approximately 4 to 6 hours.


Q: How do official sources describe the feeling of 'euphoria' sometimes mentioned with codeine use?

Regulatory labeling for the codeine component highlights the potential for the medication to lead to Opioid Abuse and Misuse. While non-therapeutic subjective experiences may be mentioned by users, official patient information focuses on the established risks of abuse and dependence.


Q: Does Zapain have a ceiling effect on pain relief?

The combination contains acetaminophen, which has a strictly limited maximum daily dose of 4000 mg due to the risk of toxicity. According to official mechanism of action descriptions, this inherent daily limit on the acetaminophen component restricts the total pain relief that can be achieved.


Q: What is the chemical difference between acetaminophen and ibuprofen regarding Zapain?

Official drug classification describes Acetaminophen, one of Zapain's components, as a non-opioid analgesic that primarily works within the central nervous system (CNS). Ibuprofen, by contrast, is categorized as a non-steroidal anti-inflammatory drug (NSAID), which primarily works by reducing inflammation elsewhere in the body.


Q: How does the body eliminate Zapain?

According to regulatory pharmacokinetic information, both active ingredients of Zapain are metabolized in the liver. They are then cleared from the body through the process of elimination in the urine via the kidneys.


Q: Can Zapain be taken safely with common over-the-counter anti-inflammatories like ibuprofen?

Regulatory documents do not specifically list ibuprofen as a contraindication. However, official warnings contain statements about potential risks when combining Zapain with any other medication due to the potential for additive side effects, and strict guidelines mandate avoiding all other products that contain acetaminophen.


Q: Are there any foods or drinks that should be avoided while taking Zapain?

Official warnings strictly prohibit the co-administration of Zapain with alcohol due to the serious risk of additive central nervous system (CNS) depression. Regulatory information states that the medicine can otherwise be taken with or without food.


Q: Does taking Zapain affect the liver over a long period of time?

Official documents indicate that the risk of Severe Hepatotoxicity, or liver damage, remains a key safety constraint due to the acetaminophen component. Additionally, long-term repeated use of codeine is associated with the risks of developing Physical Dependence.


Q: Why do some users report that Zapain is ineffective for their pain?

Official product information notes that the conversion of codeine to its active pain-relieving form, morphine, relies on the CYP2D6 enzyme. Regulatory warnings state that variations in this enzyme can affect a person's response, and the drug is contraindicated for certain ultra-rapid metabolizers.


Q: What is the official classification of Zapain as a controlled substance?

The codeine component of Zapain requires regulatory oversight. Depending on the authority and the specific product strength, this combination is typically classified as a Schedule III or Schedule IV controlled substance.


Q: Are there any common non-drug products that interact with Zapain?

The most critical non-drug warning found in official documents is the strict prohibition of alcohol consumption. Some regulatory safety research has also included examination of the co-administration with other common non-drug substances, such as potassium supplements.


Q: Is it necessary to report all over-the-counter drugs when taking Zapain?

Patient information emphasizes the need to avoid products containing acetaminophen, and cautions against combining the drug with many over-the-counter and prescription drug classes, which underscores the importance of disclosing all concurrent medication use.

How should Zapain (Acetaminophen,Codeine) be stored and disposed of?

How to Store and Dispose of Zapain (Acetaminophen/Codeine)

Zapain must be stored strictly according to regulatory conditions to maintain its stability and to ensure public safety. The medicine must not be stored above 25 C and must be kept in a dry place. It is required that the product be protected from light and remain in its original container.

Child Safety and Stability

Requirement Type Official Labeled Condition
Temperature Do not store above 25 C
Child Safety Keep this medicine out of the sight and reach of children
Stability Do not use after the stated expiry date (EXP)

Disposal Requirements

Unused or expired Zapain must be disposed of in accordance with local requirements. The official preference is to utilize a drug take-back location or mail-back program. Disposal via wastewater or regular household trash is prohibited unless following the regulatory-approved method of mixing the drug with an unappealing substance and sealing it.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Zapain (Acetaminophen,Codeine) found in:

A-Z Index: